Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
57 studies found for:    Open Studies | "Spondylitis, Ankylosing"
Show Display Options
Rank Status Study
1 Recruiting An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement
Condition: Spondylitis, Ankylosing
Interventions: Drug: Infliximab;   Drug: NSAIDs;   Drug: DMARDs
2 Recruiting Progression of Spinal Fusion in Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Intervention:
3 Recruiting Physical Training Program in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Other: Personalized physical training program
4 Recruiting Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention:
5 Recruiting A Multicenter Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Other: Placebo;   Drug: Bimekizumab
6 Recruiting Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study
Condition: Ankylosing Spondylitis
Intervention:
7 Not yet recruiting Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: etanercept (Half-Dose);   Drug: etanercept (Full-Dose);   Drug: Sulfasalazine;   Drug: Celecoxib
8 Recruiting Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondyloarthritis
Interventions: Drug: Secukinumab;   Drug: Placebo
9 Recruiting A Randomized, Double-blind, Placebo-controlled Multicenter Study of Secukinumab (AIN457) to Examine the Clinical Efficacy and the Nonsteroidal Anti-inflammatory Drug (NSAID)-Sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: AIN457/Secukinumab;   Drug: AIN457/Secukinumab Placebo
10 Recruiting Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients
Condition: Ankylosing Spondylitis
Intervention: Drug: Adalimumab
11 Recruiting Electroacupuncture for Relieving Pain in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Device: Electroacupuncture
12 Recruiting An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention:
13 Recruiting A Study to Assess Efficacy and Safety of Filgotinib in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: filgotinib;   Drug: Placebo Oral Tablet
14 Not yet recruiting A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: ENIA11;   Biological: Placebo
15 Recruiting Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes
Condition: Ankylosing Spondylitis
Interventions: Drug: NSAIDs;   Drug: anti-TNF
16 Recruiting The Effect of NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in the Spine in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: Golimumab;   Drug: Celecoxib
17 Recruiting Ankylosing Spondylitis and Antiphospholipid Antibodies
Condition: Ankylosing Spondylarthritis
Intervention: Biological: blood collection
18 Recruiting Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: TNF alpha;   Drug: NSAIDs and sulfasalazine
19 Recruiting Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA
Condition: Spondylitis, Ankylosing
Intervention: Biological: Etanercept
20 Recruiting An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis
Condition: Nonradiographic Axial Spondylitis, Ankylosing
Interventions: Drug: Group 1: Placebo;   Drug: Group 2: Ustekinumab 45 mg;   Drug: Group 3: Ustekinumab 90 mg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.